Pharmacoecomic Evaluation on Shexiang Baoxin Pills, Compound Danshen Dropping Pills and Naoxintong Capsules in the Treatment of Stable Angina Pectoris of Coronary Heart Disease

WANG Xiaoli; DONG Zhanjun; ZHANG Huiling; YUAN Yaohui; CHONG Baogui; LIU Guoqiang

doi:10.14009/j.issn.1672-2124.2023.02.021

您当前的位置：

首页 >

文章列表页 >

Pharmacoecomic Evaluation on Shexiang Baoxin Pills, Compound Danshen Dropping Pills and Naoxintong Capsules in the Treatment of Stable Angina Pectoris of Coronary Heart Disease

更新时间：2023-04-14

- Pharmacoecomic Evaluation on Shexiang Baoxin Pills, Compound Danshen Dropping Pills and Naoxintong Capsules in the Treatment of Stable Angina Pectoris of Coronary Heart Disease
- Issue 2, Pages: 230-233(2023)
- 作者机构：
  
  1. 河北医科大学第三医院药剂科
  2. 河北省人民医院药学部
  3. 河北医科大学第三医院中医科
  4. 邢台市第三医院药剂科
  5. 哈励逊国际和平医院药剂科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2023.02.021
  CLC： R259
- Published：2023，
扫描看全文
WANG Xiaoli, DONG Zhanjun, ZHANG Huiling, et al. Pharmacoecomic Evaluation on Shexiang Baoxin Pills, Compound Danshen Dropping Pills and Naoxintong Capsules in the Treatment of Stable Angina Pectoris of Coronary Heart Disease. [J]. (2):230-233(2023)
DOI：

WANG Xiaoli, DONG Zhanjun, ZHANG Huiling, et al. Pharmacoecomic Evaluation on Shexiang Baoxin Pills, Compound Danshen Dropping Pills and Naoxintong Capsules in the Treatment of Stable Angina Pectoris of Coronary Heart Disease. [J]. (2):230-233(2023) DOI： 10.14009/j.issn.1672-2124.2023.02.021.

摘要

目的：评价麝香保心丸、复方丹参滴丸与脑心通胶囊治疗冠心病稳定型心绞痛的经济性。方法：从卫生体系角度出发，构建决策树模型，采用成本-效用分析，对麝香保心丸、复方丹参滴丸与脑心通胶囊治疗冠心病稳定型心绞痛进行药物经济学评价。结果：与麝香保心丸组比较，脑心通胶囊组方案的增量成本-效用比为3 501 593.41

＞3倍人均GDP

麝香保心丸组方案更具有经济性；与复方丹参滴丸组比较，麝香保心丸组方案的成本更低，效果更好；因此，麝香保心丸组方案最具有经济性。敏感性分析显示结果具有稳健性。结论：与复方丹参滴丸、脑心通胶囊比较，麝香保心丸治疗冠心病稳定型心绞痛更具有药物经济学优势。

Abstract

OBJECTIVE: To evaluate the economical efficiency of Shexiang Baoxin pills

compound Danshen dropping pills and Naoxintong capsules in the treatment of stable angina pectoris of coronary heart disease. METHODS: Based on the perspective of health system

a decision tree model was constructed

and cost-utility analysis was used to conduct pharmacoeconomic evaluation on Shexiang Baoxin pills

compound Danshen dripping pills and Naoxintong capsules in the treatment of stable angina pectoris of coronary heart disease. RESULTS: Compared with the Shexiang Baoxin pills group

the incremental cost-utility ratio of the Naoxintong capsules group regimen was 3 501 593.41

which was greater than 3 times the GDP per capita

so that the Shexiang Baoxin pills group regimen was more economical; compared with the compound Danshin dropping pills group

the Shexiang Baoxin pills group regimen was less costly and more effective; therefore

the Shexiang Baoxin pills group regimen was the most economical. Sensitivity analysis showed that the results were robust. CONCLUSIONS: Compared with compound Danshin dropping pills and Naoxintong capsules

the Shexiang Baoxin pills has more pharmacoeconomic advantages in the treatment of stable angina pectoris in coronary heart disease.

关键词

麝香保心丸复方丹参滴丸脑心通胶囊冠心病稳定型心绞痛

Keywords

Shexiang Baoxin pillsCompound Danshen dripping pillsNaoxintong capsulesStable angina pectoris of coronary heart disease

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Evidence-Based Pharmacoeconomic Evaluation of Shexiang Baoxin Pills and Compound Danshen Dripping Pills in the Treatment of Angina Pectoris of Coronary Heart Disease

Clinical Observation of Shexiang Baoxin Pills Combined with Ivabradine in the Treatment of Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease

Pharmacoeconomic Evaluation of Compound Danshen Dropping Pills and Shexiang Baoxin Pills in the Treatment of Unstable Angina Pectoris

Systematic Review of Efficacy and Safety of Shexiang Baoxin Pills in the Treatment of Coronary Heart Disease and Angina Pectoris

Related Author

GAO Shengnan

WANG Xianying

LIU Xianxia

ZHANG Yuansheng

CHEN Lei

CHEN Jiaxian

WANG Xingdong

YANG Yuansu

Related Institution

Dept.of Cardiology, the Second Affiliated Hospital of Hainan Medical College

Dept.of Pharmacy, General Hospital of Eastern Theater Command of PLA

⁰